期刊文献+

IFN-γ联合阿霉素或依托泊苷增强TRAIL对神经母细胞瘤细胞的诱导凋亡作用 被引量:1

Combination of IFNγand Etoposide or Doxorubicin Enhances Tumor Necrotic Factor-related Aptoptosis-inducing Ligand-induced Apoptosis of Neuroblastoma Cells
下载PDF
导出
摘要 目的:探讨半胱-天冬氨酸蛋白酶8(Caspase 8)和死亡受体(DR)在肿瘤坏死因子相关凋亡诱导配体(TRAIL)诱导神经母细胞瘤(NB)细胞凋亡中的作用。方法:应用RT-PCR方法检测γ干扰素(IFN-γ)作用前后NB细胞Caspase 8 mRNA的表达;应用Western blot方法检测Caspase 8、DR4和DR5蛋白表达;应用四甲基偶氮唑蓝(MTT)比色法及流式细胞术检测IFN-γ,TRAIL,IFN-γ+TRAIL,Caspase 8抑制剂+TRAIL及IFN-γ+阿霉素/依托泊苷+TRAIL对NB细胞株生长及凋亡的影响。结果:IFN-γ在NB细胞株SKNDZ中诱导了Caspase 8mRNA及蛋白表达。SY5Y细胞对TRAIL不敏感,而IFN-γ与TRAIL或阿霉素,依托泊苷联用对SY5Y细胞有明显诱导凋亡作用。IFN-γ+TRAIL组SY5Y细胞早期凋亡率(23.09+2.35)%高于TRAIL组[(6.15±0.54)%(P<0.01)],但低于IFN-γ+阿霉素/依托泊苷+TRAIL组[(43.41±6.46)%/(38.86±7.29)%,P<0.01]。阿霉素或依托泊苷可以诱导NB细胞株DR5蛋白表达,但未诱导DR4蛋白表达。IFNγ诱导后表达Caspase 8的SKNDZ细胞对TRAIL的诱导凋亡作用仍不敏感,而阿霉素或依托泊苷处理后同时表达DR5的SKNDZ细胞对TRAIL的诱导凋亡作用相对敏感。IFN-γ+阿霉素/依托泊苷+TRAIL组SKNDZ细胞早期凋亡率(11.54±2.49)%/(13.38±1.65)%高于IFN-γ+TRAIL组(P<0.01)。结论:IFN-γ上调Caspase 8表达及化疗药阿霉素或依托泊苷诱导DR5表达可以恢复NB细胞对TRAIL的敏感性,Caspase 8和DR5在TRAIL诱导NB细胞凋亡中起着十分关键的作用。 Objective: This study aims to evaluate the role of Caspase 8 and death receptor ( DR ) in TNF-related apoptosis-inducing ligand ( TRAIL )-induced apoptosis of neuroblastoma ( NB ) cell lines. Methods: Caspase 8 mRNA expression in NB cells before and after treatment with IFNγ was monitored through reverse transcriptase-polymerase chain reaction. Caspase 8, DR5, and DR4 protein expression was monitored through Western blot analysis. The effects of IFNγ, TRAIL, IFNγ + TRAIL, Caspase 8 inhibitor + TRAIL, and IFNγ + etoposide/doxombicin + TRAIL on the growth and apoptosis of NB cells were detected through MTT and flow cytometry. Results: The expression of Caspase 8 mRNA and protein was induced by IFN7 in the NB cell line SKNDZ. SY5Y cells were resistant to TRAIL. However, the combination treatment of IFN7 + TRAIL and IFNy + etoposide/doxorubicin + TRAIL significantly induced cell apoptosis in SY5Y cells. The early stage apoptosis rate of SY5Y cells in the IFN7 + TRAIL group [ ( 23.09 ± 2.35 ) % ] was significantly higher than that in the TRAIL group [ ( 6.15 ±0.54 ) % ] ( P 〈 0.01 ), but was significantly lower than that in the IFN7 + dox/eto + TRAIL group [ ( 43.41 ± 6.46 ) ] %/ ( 38.86±7.29 ) % ] ( P 〈 0.01 ). Moreover, etoposide or doxorubicin induced DR5 but not DR4 in NB cell lines. SKNDZ cells expressing Caspase 8 after treatment with IFNγ were still resistant to TRAIL but subsequently became sensitive to TRAIL after the induction of DR5 through the treatment of etoposide or doxombicin. The early stage apoptosis rate of the IFNγ + dox/eto + TRAIL group [ ( 11.54 ± 2.49 ) %/ ( 13.38± 1.65 ) % ] was significantly higher than that of the IFNy + TRAIL group ( P 〈 0.01 ). Conclusion: Sensitization of NB cells to TRAIL may be mediated by the upregulation of Caspase 8 with IFNγ and DR5 with etoposide or doxombicin. The results suggest that Caspase 8 and DR5 play key roles in TRAIL-induced apoptosis of NB cells.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2012年第7期365-368,376,共5页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金(编号:30950021、81101528)资助~~
关键词 神经母细胞瘤 IFN-Γ 阿霉素 依托泊苷 凋亡 Neuroblastoma IFN-γ Doxorubicin Etoposide Apoptosis
  • 相关文献

参考文献10

  • 1Cohn SL,Pearson AD,London WB. The International Neu-roblastoma Risk Group (INRG) classification system:an INRG Task Force report[J].Journal of Clinical Oncology,2009,(02):289-297.doi:10.1200/JCO.2008.16.6785.
  • 2Clark PE,Polosukhina DA,Gyabaah K. TRAIL and interfer-on-alpha act synergistically to induce renal cell carcinoma apoptosis[J].The Journal of Urology,2010,(03):1166-1174.doi:10.1016/j.juro.2010.04.064.
  • 3Qu J,Zhao M,Teng Y. Interferon-α sensitizes human gastric cancer cells to TRAIL-induced apoptosis via activation of the c-CBL-dependent MAPK/ERK pathway[J].Cancer Biology and Therapy,2011,(06):494-502.doi:10.4161/cbt.12.6.15973.
  • 4Tong HX,Lu CW,Yang YM. Role of Caspase 8 as a determinant in TRAIL sensitivity of neuroblastoma cell lines[J].Pediatric Hematology and Oncology,2009,(08):549-559.doi:10.3109/08880010903271663.
  • 5佟海侠,陆春伟,王秋实,王立维.5氮杂胞苷联合干扰素-γ上调神经母细胞瘤细胞Caspase 8表达的研究[J].现代肿瘤医学,2011,19(3):432-435. 被引量:2
  • 6Tong HX,Lu CW,Zhang JH. Enhanced effect of IFNγ on the induced-apoptosis of neuroblastoma cells by cytotoxic drugs[J].Pe-diatr Hemat Oncol,2008,(06):549-558.
  • 7Cheong HJ,Lee KS,Woo IS. Up-regulation of the DR5 ex-pression by proteasome inhibitor MG132 augments TRAIL-induced apoptosis in soft tissue sarcoma cell lines[J].Cancer Res Treat,2011,(02):124-130.doi:10.4143/crt.2011.43.2.124.
  • 8Yang JF,Cao JG,Tian L. 5,7-Dimethoxyflavone sensitizes TRAIL-induced apoptosis through DR5 upregulation in hepatocel-lular carcinoma cells[J].Cancer Chemotherapy and Pharmacology,2012,(01):195-206.doi:10.1007/s00280-011-1686-9.
  • 9Moon DO,Park SY,Choi YH. Guggulsterone sensitizes hepa-toma cells to TRAIL-induced apoptosis through the induction of CHOP-dependent DR5:involvement of ROS-dependent ER-stress[J].Biochemical Pharmacology,2011,(11):1641-1650.doi:10.1016/j.bcp.2011.08.019.
  • 10Day TW,Wu CH,Safa AR. Etoposide induces protein kinase Cdeltaand caspase-3-dependent apoptosis in neuroblastoma cancer cells[J].Molecular Pharmacology,2009,(03):632-640.doi:10.1124/mol.109.054999.

二级参考文献2

共引文献1

同被引文献9

  • 1Maris JM, Hogarty MD, Bagatell R, et al. Neuroblastoma[J]. Lan- cet, 2007, 369(9579): 2106-2120.
  • 2Perwein P, Lackner H, Sovinz P, et al. Survival and late effects in children with stage 4 neurohlastoma[]]. Pediatr Blood Cancer, 57 (4): 629-635.
  • 3Yalcin B, Kremer LCM, Caron HN, et al. High-dose chemothera- py and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma[J]. Cochrane Database Syst Rev, 2010, 12(5): CD006031.
  • 4Simon T, Bertold F, Borkhardt A, et al. Treatment and outcomes of patients with relapsed, high-risk neuroblastoma: results of Ger- man triMs[J]. Pediatr Blood Cancer, 2011, 56(4) : 578-583.
  • 5Ambros PF, Ambros IM, Brodeur GM, et al. International consen sus for neuroblastoma molecular diagnostics: report from the inter national neuroblastoma risk group (INRG) biology committee[J]. BrJ Cancer, 2009, 100(9): 1471-1482.
  • 6Kushner HB, Kramer K, Modak S, et al. Differential impact of high-dose cyclophosphamide, topotecan, and vincristine in clinical subsets of patients with chemoresistaalt neuroblastoma[J]. Cancer, 2010, 116(12): 3054-3060.
  • 7Jadvar H, Connolly LP, Fahey FH, et al. PET and PET/CT in pedi- atric oncology[J]. Semin Nucl Med, 2007, 37(5): 316-331.
  • 8Dickson PV, Hamner JB, Sims TL, et al. Bevacizumab-induced transient remodeling of the vasculature in neuroblastoma xeno- grafts results in improved delivery and efficacy of systemically ad- ministered chemotherapy[J]. Clin Cancer Res, 2007, 13(13): 3942-3950.
  • 9Benesch M, Windelberg M, Sauseng W, et al. Compassionate use of bevacizumab (Avastin) in children and young adults with refrac- tory or recurrent solid tumors[J]. Ann Oncol, 2008, 19(4): 807-813.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部